EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Regulation of insulin-like growth factor (IGF) binding proteins in transgenic mice with altered expression of growth hormone and IGF-I


Endocrinology 129(3): 1201-1206
Regulation of insulin-like growth factor (IGF) binding proteins in transgenic mice with altered expression of growth hormone and IGF-I
The insulin-like growth factors (IGFs) are present in extracellular fluids bound to specific, high affinity IGF binding proteins (IGFBPs). IGFBPs are believed to mediate IGF transport to tissues and to modulate their actions on target cells. To determine whether IGF-I can modulate IGFBP concentrations in blood and to distinguish the effects of IGF-I from those of somatotropin (GH), serum IGFBP concentration was assessed in 4 genotypically distinct groups of sibling transgenic mice that differed in respect to their expression of IGF-I and GH. This unique physiological situation was created by crossing IGF-I transgenic mice to GH-deficient, dwarf mice in whom somatotrophs were genetically ablated by the expression of a diphtheria toxin transgene in the somatotrophs. Because both transgenic mouse lines were hemizygous for their respective transgene, progeny of the cross differed genotypically, according to whether or not they carried one or both transgenes, and phenotypically in regard to their relative expression of IGF-I and GH. GH-deficient mice showed a 15.7-fold decrease in serum IGF-I and a 5.5-fold decrease in serum IGFBP-3, but no change in a serum doublet band of 29 000 to 34 000 Mr, as assessed by ligand blotting. When IGF-I was expressed in the GH-deficient mice, serum levels of IGF-I and IGFBP-3 were 69 and 64% of those in normal sera, resp. The 29 000 to 34 000 Mr doublet bands also increased. The ternary 150 kDa IGF-IGFBP complex, however, was not restored, presumably because IGF-I has no influence on the expression of the acid-labile subunit in this complex. In mice with IGF-I overexpression, serum IGFBP-3 was increased 2.1-fold and the sum of the 29 000 to 34 000 doublet bands was increased 2.9-fold. Immunoblotting showed that the changes in the 29 000 to 34 000 Mr forms observed by ligand blotting appeared to be predominantly due to changes in IGFBP-2. The results show that IGF-I can induce IGFBP-3 and IGFBP-2 independently of GH and that IGF-I is a major controller of these binding proteins.


Accession: 002477156

PMID: 1714829

DOI: 10.1210/endo-129-3-1201



Related references

Regulation of insulin like growth factor igf binding proteins in transgenic mice and with altered expression of growth hormone and igf i. Endocrinology 129(3): 1201-1206, 1991

Interactions of insulin-like growth factor (IGF)-II and growth hormone in vivo: circulating levels of IGF-I and IGF-binding proteins in transgenic mice. European Journal of Endocrinology 137(6): 701-708, 1997

Interactions of insulin-like growth factor (IGF)-II and growth hormone in vivo: circulating levels of IGF-I and IGF-binding proteins in transgenic mice. European Journal of Endocrinology 137(6): 701-708, 1998

Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients. Journal of Clinical Endocrinology and Metabolism 74(4): 743-750, 1992

Expression of serum insulin like growth factors insulin like growth factor binding proteins and the growth hormone binding protein in heterozygote relatives of ecuadorian growth hormone receptor deficient patients. Journal of Clinical Endocrinology & Metabolism 74(4): 743-750, 1992

Tissue-specific regulation of growth hormone (GH) receptor and insulin-like growth factor-I gene expression in the pituitary and liver of GH-deficient (lit/lit) mice and transgenic mice that overexpress bovine GH (bGH) or a bGH antagonist. Endocrinology 145(4): 1564-1570, 2004

Tissue-specific regulation of growth hormone receptor and insulin-like growth factor-I gene expression in the pituitary and liver of GH-deficient mice and transgenic mice that overexpress bovine GH or a bGH antagonist. Endocrinology 145(4): 1564-1570, April, 2004

Altered expression of insulin-like growth factor-II and insulin-like growth factor binding proteins during intrauterine growth restriction in guinea pigs. Placenta 21(7): A 6, September, 2000

Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2. Endocrinology 142(5): 1889-1898, 2001

Expression of insulin-like growth factor binding proteins (IGFBPs) in IGFBP-1 transgenic mice. Journal of Endocrinology 152(1): 99-108, 1997